STAD (Stockholm Prevents Alcohol and Drug Problems), Stockholm, Sweden.
Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Eur J Public Health. 2022 Oct 3;32(5):760-765. doi: 10.1093/eurpub/ckac105.
Reports indicate that the proportion of adults using drugs of abuse has been increasing in recent years in Europe. Although there are various indicators of increased drug use in Sweden over time, few studies could demonstrate an increase in the proportion of adults using drugs. To investigate changes in drug use prevalence over time, drug testing at the workplace has been used for a 25-year period.
The urine samples of employees sent by occupational health services from all over Sweden during a 25-year period were analyzed. The analyzing capacity increased over time (from 3411 in 1994 to 60 315 samples analyzed in 2019), and the majority of the samples was analyzed for the following drugs: cannabis (tetrahydrocannabinol), amphetamine, opiates, cocaine, and benzodiazepines.
There was an overall increase in the proportion of samples that tested positive for illicit drugs over a 25-year period. This increase seemed to take place step-wise, with phases of linear increases and plateaus that over time became shorter. About 1.3% of samples tested positive for drugs in 1994, whereas 5.6% tested positive in 2019. Since 2007, the rate of positive samples has increased for cannabis and decreased for benzodiazepines. Although the rate of samples tested positive for opiates had remained relatively stable over the last 20 years, this rate had increased for amphetamine and cocaine between 2013 and 2019.
The results indicate that the use of illicit drugs among employees at Swedish workplaces has increased during a 25-year period.
报告显示,近年来欧洲滥用药物的成年人比例有所增加。尽管瑞典在一段时间内有各种药物使用增加的指标,但很少有研究能够证明成年人使用药物的比例有所增加。为了调查药物使用流行率随时间的变化,在工作场所进行药物检测已经使用了 25 年。
分析了来自瑞典各地职业健康服务机构在 25 年内发送的员工尿液样本。分析能力随着时间的推移而增加(从 1994 年的 3411 个样本增加到 2019 年的 60315 个样本),大多数样本分析了以下药物:大麻(四氢大麻酚)、苯丙胺、阿片类药物、可卡因和苯二氮䓬类药物。
在 25 年内,尿液样本中检测出非法药物呈总体上升趋势。这种增长似乎呈阶梯式上升,有线性增长阶段和平台阶段,随着时间的推移,这些阶段的间隔越来越短。1994 年有 1.3%的样本检测出药物阳性,而 2019 年有 5.6%的样本检测出药物阳性。自 2007 年以来,大麻的阳性样本率有所上升,而苯二氮䓬类药物的阳性样本率有所下降。尽管阿片类药物的阳性样本率在过去 20 年相对稳定,但 2013 年至 2019 年期间,苯丙胺和可卡因的阳性样本率有所上升。
结果表明,在瑞典工作场所,员工中非法药物的使用在 25 年内有所增加。